Literature DB >> 3667819

Estimation of doxorubicin and doxorubicinol by high-performance liquid chromatography and advanced automated sample processor.

N A Dobbs1, C A James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3667819     DOI： 10.1016/0378-4347(87)80171-8

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.

Authors:  David L Chin; Bert L Lum; Branimir I Sikic
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-11-05       Impact factor: 3.205

2.  Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology Group.

Authors:  Patrick Thompson; Heather E Wheeler; Shannon M Delaney; Rachel Lorier; Ulrich Broeckel; Meenakshi Devidas; Gregory H Reaman; Kathleen Scorsone; Lillian Sung; M Eileen Dolan; Stacey L Berg
Journal:  Cancer Chemother Pharmacol       Date:  2014-08-14       Impact factor: 3.333

3.  Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.

Authors:  N A Dobbs; C J Twelves; H Gillies; C A James; P G Harper; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancer.

Authors:  C J Twelves; N A Dobbs; M Aldhous; P G Harper; R D Rubens; M A Richards
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.